Benjamin Cogné

Benjamin Cogné

Auto-generated profile, based on publicly available information

Benjamin Cogné

Nantes Université, CHU de Nantes, CNRS, INSERM, l’institut du thorax, Nantes, France

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MCMargot A. Cousin
Margot A. Cousin
BCBlake A. Creighton
Blake A. Creighton
KBKeith A. Breau
Keith A. Breau
RSRebecca C. Spillmann
Rebecca C. Spillmann
ETErin Torti
Erin Torti
DLDamaris N. Lorenzo
Damaris N. Lorenzo

15 May 2019 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
LLLina Liang
Lina Liang
XLXia Li
Xia Li
SMSébastien Moutton
Sébastien Moutton
SVSamantha Schrier Vergano
Samantha Schrier Vergano
BCBenjamin Cogné
Benjamin Cogné
QWQing Wang
Qing Wang
KCNMA1 encodes the large-conductance Ca2+- and voltage-activated K+ (BK) potassium channel α-subunit, and pathogenic gain-of-function variants in this gene have been associated with a dominant form of generalized epilepsy and paroxysmal dyskinesia. Here, we genetically and functionally characterize eight novel loss-of-function (LoF) variants of KCNMA1. Genome or exome sequencing and the participation in the international Matchmaker Exchange effort allowed for the identification of novel KCNMA1 variants. Patch clamping was used to assess functionality of mutant BK channels. The KCNMA1 variants p.(Ser351Tyr), p.(Gly356Arg), p.(Gly375Arg), p.(Asn449fs) and p.(Ile663Val) abolished the BK current, whereas p.(Cys413Tyr) and p.(Pro805Leu) reduced the BK current amplitude and shifted the activation curves toward positive potentials. The p.(Asp984Asn) variant reduced the current amplitude without affecting kinetics. A phenotypic analysis of the patients carrying the recurrent p.(Gly375Arg) de novo missense LoF variant revealed a novel syndromic neurodevelopmental disorder associated with severe developmental delay, visceral and cardiac malformations, connective tissue presentations with arterial involvement, bone dysplasia and characteristic dysmorphic features. Patients with other LoF variants presented with neurological and developmental symptoms including developmental delay, intellectual disability, ataxia, axial hypotonia, cerebral atrophy and speech delay/apraxia/dysarthria. Therefore, LoF KCNMA1 variants are associated with a new syndrome characterized by a broad spectrum of neurological phenotypes and developmental disorders. LoF variants of KCNMA1 cause a new syndrome distinctly different from gain-of-function variants in the same gene.

16 May 2025 in Nature Genetics
Verified
Journal Article
Open access
PDF file
CNCaroline Nava
Caroline Nava
BCBenjamin Cogne
Benjamin Cogne
ASAmandine Santini
Amandine Santini
ELElsa Leitão
Elsa Leitão
FLFrançois Lecoquierre
François Lecoquierre
CDChristel Depienne
Christel Depienne
The major spliceosome contains five small nuclear RNAs (snRNAs; U1, U2, U4, U5 and U6) essential for splicing. Variants in RNU4-2, encoding U4, cause a neurodevelopmental disorder called ReNU syndrome. We investigated de novo variants in 50 snRNA-encoding genes in a French cohort of 23,649 individuals with rare disorders and gathered additional cases through international collaborations. Altogether, we identified 145 previously unreported probands with (likely) pathogenic variants in RNU4-2 and 21 individuals with de novo and/or recurrent variants in RNU5B-1 and RNU5A-1, encoding U5. Pathogenic variants typically arose de novo on the maternal allele and cluster in regions critical for splicing. RNU4-2 variants mainly localize to two structures, the stem III and T-loop/quasi-pseudoknot, which position the U6 ACAGAGA box for 5′ splice site recognition and associate with different phenotypic severity. RNU4-2 variants result in specific defects in alternative 5′ splice site usage and methylation patterns (episignatures) that correlate with variant location and clinical severity. This study establishes RNU5B-1 as a neurodevelopmental disorder gene, suggests RNU5A-1 as a strong candidate and highlights the role of de novo variants in snRNAs.

14 May 2022 in Genetics in Medicine
Verified
Journal Article
Closed access
SCSilvestre Cuinat
Silvestre Cuinat
MNMathilde Nizon
Mathilde Nizon
BIBertrand Isidor
Bertrand Isidor
ASAlexander Stegmann
Alexander Stegmann
RJRichard H. van Jaarsveld
Richard H. van Jaarsveld
BCBenjamin Cogné
Benjamin Cogné

22 February 2022 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MBMartin Broly
Martin Broly
BPBogdan V. Polevoda
Bogdan V. Polevoda
KAKamel M. Awayda
Kamel M. Awayda
NTNing Tong
Ning Tong
JLJenna Lentini
Jenna Lentini
MOMitchell R. O’connell
Mitchell R. O’connell

15 July 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
SCSalima El Chehadeh
Salima El Chehadeh
KHKyung Ah Han
Kyung Ah Han
DKDongwook Kim
Dongwook Kim
GJGyubin Jang
Gyubin Jang
SBSomayeh Bakhtiari
Somayeh Bakhtiari
JUJI WON UM
JI WON UM
SLITRK2 is a single-pass transmembrane protein expressed at postsynaptic neurons that regulates neurite outgrowth and excitatory synapse maintenance. In the present study, we report on rare variants (one nonsense and six missense variants) in SLITRK2 on the X chromosome identified by exome sequencing in individuals with neurodevelopmental disorders. Functional studies showed that some variants displayed impaired membrane transport and impaired excitatory synapse-promoting effects. Strikingly, these variations abolished the ability of SLITRK2 wild-type to reduce the levels of the receptor tyrosine kinase TrkB in neurons. Moreover, Slitrk2 conditional knockout mice exhibited impaired long-term memory and abnormal gait, recapitulating a subset of clinical features of patients with SLITRK2 variants. Furthermore, impaired excitatory synapse maintenance induced by hippocampal CA1-specific cKO of Slitrk2 caused abnormalities in spatial reference memory. Collectively, these data suggest that SLITRK2 is involved in X-linked neurodevelopmental disorders that are caused by perturbation of diverse facets of SLITRK2 function.